EP1144997A3 - Methods and compounds for modulating nuclear receptor activity - Google Patents
Methods and compounds for modulating nuclear receptor activityInfo
- Publication number
- EP1144997A3 EP1144997A3 EP99916206A EP99916206A EP1144997A3 EP 1144997 A3 EP1144997 A3 EP 1144997A3 EP 99916206 A EP99916206 A EP 99916206A EP 99916206 A EP99916206 A EP 99916206A EP 1144997 A3 EP1144997 A3 EP 1144997A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- compounds
- methods
- receptor activity
- nuclear receptor
- modulating nuclear
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6875—Nucleoproteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
- C07K14/721—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/72—Assays involving receptors, cell surface antigens or cell surface determinants for hormones
- G01N2333/723—Steroid/thyroid hormone superfamily, e.g. GR, EcR, androgen receptor, oestrogen receptor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/20—Screening for compounds of potential therapeutic value cell-free systems
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7995698P | 1998-03-30 | 1998-03-30 | |
US79956P | 1998-03-30 | ||
US11301498P | 1998-12-16 | 1998-12-16 | |
US11314698P | 1998-12-16 | 1998-12-16 | |
US113014P | 1998-12-16 | ||
US113146P | 1998-12-16 | ||
PCT/US1999/006937 WO1999050658A2 (en) | 1998-03-30 | 1999-03-30 | Methods and compounds for modulating nuclear receptor activity |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1144997A2 EP1144997A2 (en) | 2001-10-17 |
EP1144997A3 true EP1144997A3 (en) | 2002-08-28 |
Family
ID=27373576
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP99916206A Withdrawn EP1144997A3 (en) | 1998-03-30 | 1999-03-30 | Methods and compounds for modulating nuclear receptor activity |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1144997A3 (en) |
JP (1) | JP2002516983A (en) |
KR (1) | KR20010042373A (en) |
AU (1) | AU3457199A (en) |
CA (1) | CA2324060A1 (en) |
WO (1) | WO1999050658A2 (en) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2323575A1 (en) * | 1998-03-30 | 1999-11-25 | Regents Of The University Of California | Methods and compounds for modulating nuclear receptor coactivator binding |
WO2000052050A2 (en) * | 1999-03-01 | 2000-09-08 | Karo Bio Ab | Homology models of the glucocorticoid receptor |
WO2001027622A1 (en) | 1999-10-14 | 2001-04-19 | Bristol-Myers Squibb Company | Crystallographic structure of the androgen receptor ligand binding domain |
FR2801311B1 (en) * | 1999-11-22 | 2005-08-26 | Centre Nat Rech Scient | POLYPEPTIDES DERIVED FROM THE NUCLEAR RECEPTOR OF VITAMIN D, AND USES THEREOF IN PARTICULAR IN THE SCREENING OF ANALOGUES OF VITAMIN D |
EP1297175A4 (en) * | 2000-06-30 | 2005-02-02 | Univ California | Methods and compounds for modulating nuclear receptor coactivator binding |
DE10036461A1 (en) * | 2000-07-25 | 2002-02-07 | Bayer Ag | Ligand binding domain of the Ultraspiracle (USP) protein |
JP4593754B2 (en) * | 2000-10-13 | 2010-12-08 | 一般財団法人 化学物質評価研究機構 | Method for determining 50% inhibitory concentration of chemical substances |
JP2002296282A (en) * | 2001-04-02 | 2002-10-09 | Enbiotec Laboratories:Kk | Method of detecting exogeneous endocrine disturbing substance |
WO2003005025A1 (en) * | 2001-07-03 | 2003-01-16 | Biovitrum Ab | Methods for identifying compounds modulating the activity of ppar-gamma |
GB0209507D0 (en) * | 2002-04-25 | 2002-06-05 | Karobio Ab | Nuclear receptor structure |
US7302347B2 (en) * | 2002-12-10 | 2007-11-27 | The Regents Of The University Of California | Method for creating specific, high affinity nuclear receptor pharmaceuticals |
WO2005022436A1 (en) * | 2003-08-29 | 2005-03-10 | National Institute Of Advanced Industrial Science And Technology | Protein structure three-dimensional display system for indication of protein function manifestation mechanism |
US7264813B2 (en) | 2003-09-24 | 2007-09-04 | Nikken Sohonsha Corporation | Therapeutic uses of Dunaliella powder |
EP1680447A2 (en) * | 2003-10-24 | 2006-07-19 | Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. | Orthogonal gene switches |
KR20110110052A (en) * | 2010-03-31 | 2011-10-06 | (주)아모레퍼시픽 | Composition for beauty of skin containing coumestrol or soy bean extract with coumestrol |
WO2011156518A2 (en) | 2010-06-10 | 2011-12-15 | Aragon Pharmaceuticals, Inc. | Estrogen receptor modulators and uses thereof |
BR112014014124A2 (en) | 2011-12-14 | 2017-08-22 | Seragon Pharmaceutical Inc | FLUORINATED ESTROGEN RECEPTOR MODULATORS AND THEIR USES |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5650489A (en) * | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
ATE148889T1 (en) * | 1991-09-18 | 1997-02-15 | Affymax Tech Nv | METHOD FOR SYNTHESIS OF VARIOUS COLLECTIONS OF OLIGOMERS |
JP3394777B2 (en) * | 1993-05-27 | 2003-04-07 | セレクタイド コーポレーション | Topologically separated, encoded solid-phase library |
IL106106A0 (en) * | 1993-06-22 | 1993-10-20 | Interpharm Lab Ltd | Library of polymeric molecules and its preparation |
JP2000502086A (en) * | 1995-12-13 | 2000-02-22 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | Nuclear receptor ligands and ligand binding domains |
-
1999
- 1999-03-30 CA CA002324060A patent/CA2324060A1/en not_active Abandoned
- 1999-03-30 WO PCT/US1999/006937 patent/WO1999050658A2/en not_active Application Discontinuation
- 1999-03-30 EP EP99916206A patent/EP1144997A3/en not_active Withdrawn
- 1999-03-30 AU AU34571/99A patent/AU3457199A/en not_active Abandoned
- 1999-03-30 JP JP2000541516A patent/JP2002516983A/en not_active Withdrawn
- 1999-03-30 KR KR1020007010940A patent/KR20010042373A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1144997A2 (en) | 2001-10-17 |
WO1999050658A2 (en) | 1999-10-07 |
WO1999050658A3 (en) | 2001-08-16 |
KR20010042373A (en) | 2001-05-25 |
AU3457199A (en) | 1999-10-18 |
JP2002516983A (en) | 2002-06-11 |
CA2324060A1 (en) | 1999-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2327787B (en) | Methods and systems for knowledge management | |
AU9790198A (en) | Compounds and methods | |
AU6347498A (en) | Catheter system for emboli containment | |
AU1556301A (en) | Data distribution system and recorder for use therein | |
AU9298098A (en) | Amino-substituted compounds, methods, and compositions for inhibiting parp activity | |
AU1651701A (en) | Data distribution system and recorder for use therein | |
EP1144997A3 (en) | Methods and compounds for modulating nuclear receptor activity | |
AU9298198A (en) | Di-n-heterocyclic compounds, methods, and compositions for inhibiting parp activity | |
AU7819598A (en) | Soil testing assemblies | |
AU7134198A (en) | Improved cell design for a trawl system and methods | |
AU3544899A (en) | Multiple reactor containment building | |
AU2032397A (en) | Biodecontamination reactor | |
AU5279798A (en) | Urine bag assemblies | |
AU2668699A (en) | Methods and compositions for modulating leptin activity | |
AU4109097A (en) | Interaction area for data representation | |
AU1038599A (en) | Method for secure storage management | |
HK1028665A1 (en) | Apparatus for passbook management | |
AUPP696798A0 (en) | Improved reactor | |
EP0882802A4 (en) | Method for assaying telomerase activity | |
AU1033397A (en) | Biogas reactor | |
AU9167698A (en) | Mini-stencil and device for using same | |
AU3852997A (en) | Phenoxypropanolamines having beta3-adrenergic antagonist activity | |
AU6351298A (en) | Containment system | |
AU9370998A (en) | Transformer/reactor | |
AU8115298A (en) | Catalytic reactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20001024 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
XX | Miscellaneous |
Free format text: DERZEIT SIND DIE WIPO-PUBLIKATIONSDATEN A3 NICHT VERFUEGBAR. |
|
PUAK | Availability of information related to the publication of the international search report |
Free format text: ORIGINAL CODE: 0009015 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
17Q | First examination report despatched |
Effective date: 20050209 |
|
17Q | First examination report despatched |
Effective date: 20050209 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20061003 |